Trial Profile
Effect of Vaginal Estrogen on Asymptomatic Microhematuria (AMH): A Randomized Controlled Trial [EVER Study]
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 16 Mar 2023
Price :
$35
*
At a glance
- Drugs Conjugated estrogens (Primary)
- Indications Haematuria
- Focus Therapeutic Use
- Acronyms EVER study
- 09 Dec 2020 Status changed from recruiting to discontinued.
- 15 Mar 2016 Planned End Date changed from 1 Oct 2015 to 1 Dec 2017 as per ClinicalTrials.gov record.
- 15 Mar 2016 Planned primary completion date changed from 1 Sep 2015 to 1 Sep 2017 as per ClinicalTrials.gov record.